RT Journal Article SR Electronic T1 Occurrence of Four Dengue Virus Serotypes and Chikungunya Virus in Kilombero, Tanzania during Dengue Outbreak in 2018 JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.10.09.20209783 DO 10.1101/2020.10.09.20209783 A1 Beatrice Chipwaza A1 Robert David Sumaye A1 Maja Weisser A1 Winfrid Gingo A1 Nicholas Kim-Wah Yeo A1 Siti Naqiah Amrun A1 Fredros O. Okumu A1 Lisa F.P. Ng YR 2020 UL http://medrxiv.org/content/early/2020/10/13/2020.10.09.20209783.abstract AB Background Dengue and Chikungunya viruses can cause large-scale epidemics with attack rates exceeding 80%. In Tanzania, there have been repeated outbreaks of dengue fever, the most recent one in 2018 and 2019 mostly reported in coastal areas. Despite its importance, there is limited knowledge on epidemiology of dengue (DENV) and chikungunya (CHIKV) in Tanzania. This study was conducted to investigate the prevalence of DENV and CHIKV in Kilombero district, South-Eastern Tanzania.Methods A cross-sectional study was conducted at Kibaoni Health Center, in Kilombero district, in the rainy and dry seasons of 2018. Febrile patients of any age and gender were enrolled. Blood samples were taken and screened for DENV and CHIKV viral RNA by real-time RT-PCR assays.Results A total of 294 patients were recruited. Most were females (65%), and aged between 14⍰25 years (33%). DENV and CHIKV were detected in 29 (9.9%) and 3 (1.0%) patients, respectively. DENV was detected across all age groups and during both dry and rainy seasons. Although all four DENV serotypes were detected, serotypes 1 and 3 dominated and were present in 14 patients (42.4%) each. Additionally, the study showed DENV-1 and DENV-3 co-infections.Conclusion This study reveals the co-circulation of all four DENV serotypes and CHIKV in Kilombero district. Importantly, we report the first occurrence of DENV-4 in Tanzania. Unlike previous DENV outbreaks caused by DENV-2, the 2018 outbreak was dominated by DENV-1 and DENV-3. Occurrence of all serotypes suggests the possibility of having severe clinical outcomes in future DENV epidemics in Tanzania.Competing Interest StatementLFPN has filed a technology disclosure for the RT-PCR multiplex (SIgN/P/11138/00/PCT). All other authors declare no competing interests.Funding StatementThis research work was funded by Ifakara Health Institute, Tanzania through Director's Research and Innovation Fund award. The initial tests and optimizations were funded by USAID-Zika Grand Challenges grant and core research grant provided to Singapore Immunology Network by Biomedical Research Council, A*STAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:National Health Research Ethics Review Committee National Institute for Medical Research 2448 Ocean Road P.O. Box 9653 Dar es Salaam, Tanzania Tel: +255 22 2121400 Fax: 255 22 2121360 All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.DENVdengue virusCHIKchikungunya virusRT-PCRreverse transcription polymerase chain reactionDHFdengue hemorrhagic feverDSSdengue shock syndromeITCIfakara Town CouncilKHCKibaoni Health CenterIHIIfakara Health InstituteNTCNon template control